These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1475 related articles for article (PubMed ID: 19092348)
21. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study. Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231 [TBL] [Abstract][Full Text] [Related]
22. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. Abrams RA; Grochow LB; Chakravarthy A; Sohn TA; Zahurak ML; Haulk TL; Ord S; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL; Yeo CJ Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1039-46. PubMed ID: 10421536 [TBL] [Abstract][Full Text] [Related]
23. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). Corsini MM; Miller RC; Haddock MG; Donohue JH; Farnell MB; Nagorney DM; Jatoi A; McWilliams RR; Kim GP; Bhatia S; Iott MJ; Gunderson LL J Clin Oncol; 2008 Jul; 26(21):3511-6. PubMed ID: 18640932 [TBL] [Abstract][Full Text] [Related]
24. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial. Toledano A; Azria D; Garaud P; Fourquet A; Serin D; Bosset JF; Miny-Buffet J; Favre A; Le Floch O; Calais G J Clin Oncol; 2007 Feb; 25(4):405-10. PubMed ID: 17264336 [TBL] [Abstract][Full Text] [Related]
26. Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma. Schwarz RE; Keny H Hepatogastroenterology; 2001; 48(41):1493-8. PubMed ID: 11677994 [TBL] [Abstract][Full Text] [Related]
27. Adjuvant regional chemotherapy in advanced pancreatic cancer: results of a prospective study. Beger HG; Link KH; Gansauge F Hepatogastroenterology; 1998; 45(21):638-43. PubMed ID: 9684109 [TBL] [Abstract][Full Text] [Related]
28. The case for routine use of adjuvant therapy in pancreatic cancer. Kennedy EP; Yeo CJ J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543 [TBL] [Abstract][Full Text] [Related]
29. Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003. Abrams RA; Yeo CJ Surg Oncol Clin N Am; 2004 Oct; 13(4):621-38, ix. PubMed ID: 15350938 [TBL] [Abstract][Full Text] [Related]
30. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma. Pendurthi TK; Hoffman JP; Ross E; Johnson DE; Eisenberg BL Am Surg; 1998 Jul; 64(7):686-92. PubMed ID: 9655283 [TBL] [Abstract][Full Text] [Related]
31. Liver perfusion chemotherapy for selected patients at a high-risk of liver metastasis after resection of duodenal and ampullary cancers. Noda T; Ohigashi H; Ishikawa O; Eguchi H; Yamada T; Sasaki Y; Yano M; Imaoka S Ann Surg; 2007 Nov; 246(5):799-805. PubMed ID: 17968172 [TBL] [Abstract][Full Text] [Related]
32. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384 [TBL] [Abstract][Full Text] [Related]
33. [Prospective randomized trial comparing modified FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus 5-FU alone for the treatment of non-resectable pancreatic and biliary tract carcinomas (the 1st trial in non-resectable patients). Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract]. Takada T; Kato H; Sasaki M; Matsushiro T; Yamauchi H; Kajihara T; Watanabe G; Hanaue H; Yoshida K; Shimizu T Gan To Kagaku Ryoho; 1992 Aug; 19(9):1295-301. PubMed ID: 1503483 [TBL] [Abstract][Full Text] [Related]
34. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382 [TBL] [Abstract][Full Text] [Related]
35. [The curative surgery of periampullary tumors. The results of 48 resections]. de Almeida JC; Bettencourt A; Costa CS; de Almeida JM Acta Med Port; 1995 Jun; 8 Suppl 1():S35-9. PubMed ID: 7653304 [TBL] [Abstract][Full Text] [Related]
36. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. Neoptolemos JP; Stocken DD; Friess H; Bassi C; Dunn JA; Hickey H; Beger H; Fernandez-Cruz L; Dervenis C; Lacaine F; Falconi M; Pederzoli P; Pap A; Spooner D; Kerr DJ; Büchler MW; N Engl J Med; 2004 Mar; 350(12):1200-10. PubMed ID: 15028824 [TBL] [Abstract][Full Text] [Related]
37. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686 [TBL] [Abstract][Full Text] [Related]
38. Is duodenal invasion a relevant prognosticator in patients undergoing adjuvant chemoradiotherapy for distal common bile duct cancer? Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1186-90. PubMed ID: 19962835 [TBL] [Abstract][Full Text] [Related]
39. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas. Sa Cunha A; Rault A; Laurent C; Adhoute X; Vendrely V; Béllannée G; Brunet R; Collet D; Masson B J Am Coll Surg; 2005 Sep; 201(3):359-65. PubMed ID: 16125068 [TBL] [Abstract][Full Text] [Related]
40. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial. Mornex F; Girard N; Scoazec JY; Bossard N; Ychou M; Smith D; Seitz JF; Valette PJ; Roy P; Rouanet P; Ducreux M; Partensky C Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1471-8. PubMed ID: 16793214 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]